- Home
- PTCT vs TDS Comparison
PTCT vs TDS Comparison
Compare PTCT & TDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTCT
- TDS
- Stock Information
- Founded
- PTCT 1998
- TDS 1968
- Country
- PTCT United States
- TDS United States
- Employees
- PTCT N/A
- TDS N/A
- Industry
- PTCT Biotechnology: Pharmaceutical Preparations
- TDS Telecommunications Equipment
- Sector
- PTCT Health Care
- TDS Telecommunications
- Exchange
- PTCT Nasdaq
- TDS Nasdaq
- Market Cap
- PTCT 3.7B
- TDS 3.9B
- IPO Year
- PTCT 2013
- TDS N/A
- Fundamental
- Price
- PTCT $50.34
- TDS $33.21
- Analyst Decision
- PTCT Buy
- TDS Buy
- Analyst Count
- PTCT 14
- TDS 2
- Target Price
- PTCT $63.57
- TDS $50.00
- AVG Volume (30 Days)
- PTCT 939.9K
- TDS 742.4K
- Earning Date
- PTCT 08-07-2025
- TDS 08-01-2025
- Dividend Yield
- PTCT N/A
- TDS 0.48%
- EPS Growth
- PTCT N/A
- TDS N/A
- EPS
- PTCT 7.51
- TDS N/A
- Revenue
- PTCT $1,772,758,000.00
- TDS $4,856,000,000.00
- Revenue This Year
- PTCT $121.50
- TDS N/A
- Revenue Next Year
- PTCT N/A
- TDS $0.40
- P/E Ratio
- PTCT $6.72
- TDS N/A
- Revenue Growth
- PTCT 91.12
- TDS N/A
- 52 Week Low
- PTCT $28.72
- TDS $17.90
- 52 Week High
- PTCT $58.38
- TDS $41.21
- Technical
- Relative Strength Index (RSI)
- PTCT 54.78
- TDS 42.77
- Support Level
- PTCT $49.47
- TDS $33.19
- Resistance Level
- PTCT $52.45
- TDS $33.89
- Average True Range (ATR)
- PTCT 1.54
- TDS 0.92
- MACD
- PTCT -0.09
- TDS -0.11
- Stochastic Oscillator
- PTCT 49.17
- TDS 2.91
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
About TDS Telephone and Data Systems Inc.
Telephone and Data Systems Inc is a diversified telecommunications operator that provides mobile, telephone, and broadband services. The company's segments include UScellular Wireless, UScellular Towers, and TDS Telecom. It generates maximum revenue from the UScellular Wireless segment.